Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vasectomy and increased risk of prostate cancer.
Perlman JA, Brawley OW, Ford LG, Kramer BS. Perlman JA, et al. Among authors: ford lg. JAMA. 1993 Aug 11;270(6):706-7. doi: 10.1001/jama.1993.03510060051021. JAMA. 1993. PMID: 8336364 No abstract available.
5-Alpha-reductase inhibition and prostate cancer prevention.
Brawley OW, Ford LG, Thompson I, Perlman JA, Kramer BS. Brawley OW, et al. Among authors: ford lg. Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):177-82. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8049641 Review.
Estrogen replacement therapy in breast cancer survivors.
Perlman JA, Johnson K, Nayfield S, Ford LG. Perlman JA, et al. Among authors: ford lg. JAMA. 1995 Feb 22;273(8):619-20; author reply 621. doi: 10.1001/jama.1995.03520320027029. JAMA. 1995. PMID: 7844867 No abstract available.
Design of the Prostate Cancer Prevention Trial (PCPT).
Feigl P, Blumenstein B, Thompson I, Crowley J, Wolf M, Kramer BS, Coltman CA Jr, Brawley OW, Ford LG. Feigl P, et al. Among authors: ford lg. Control Clin Trials. 1995 Jun;16(3):150-63. doi: 10.1016/0197-2456(94)00xxx-m. Control Clin Trials. 1995. PMID: 7540965 Clinical Trial.
Phase III prostate cancer chemoprevention trials.
Parnes HL, Brawley OW, Minasian LM, Ford LG. Parnes HL, et al. Among authors: ford lg. Recent Results Cancer Res. 2014;202:73-7. doi: 10.1007/978-3-642-45195-9_9. Recent Results Cancer Res. 2014. PMID: 24531780
The potential for hormonal prevention trials.
Ford LG, Brawley OW, Perlman JA, Nayfield SG, Johnson KA, Kramer BS. Ford LG, et al. Cancer. 1994 Nov 1;74(9 Suppl):2726-33. doi: 10.1002/1097-0142(19941101)74:9+<2726::aid-cncr2820741823>3.0.co;2-s. Cancer. 1994. PMID: 7954293 Review.
Tamoxifen therapy for breast cancer and endometrial cancer risk.
Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E, Perlman JA, Ford L. Bernstein L, et al. J Natl Cancer Inst. 1999 Oct 6;91(19):1654-62. doi: 10.1093/jnci/91.19.1654. J Natl Cancer Inst. 1999. PMID: 10511593
Prevention and early detection of prostate cancer.
Cuzick J, Thorat MA, Andriole G, Brawley OW, Brown PH, Culig Z, Eeles RA, Ford LG, Hamdy FC, Holmberg L, Ilic D, Key TJ, La Vecchia C, Lilja H, Marberger M, Meyskens FL, Minasian LM, Parker C, Parnes HL, Perner S, Rittenhouse H, Schalken J, Schmid HP, Schmitz-Dräger BJ, Schröder FH, Stenzl A, Tombal B, Wilt TJ, Wolk A. Cuzick J, et al. Among authors: ford lg. Lancet Oncol. 2014 Oct;15(11):e484-92. doi: 10.1016/S1470-2045(14)70211-6. Lancet Oncol. 2014. PMID: 25281467 Free PMC article. Review.
Potential role of tamoxifen in prevention of breast cancer.
Nayfield SG, Karp JE, Ford LG, Dorr FA, Kramer BS. Nayfield SG, et al. Among authors: ford lg. J Natl Cancer Inst. 1991 Oct 16;83(20):1450-9. doi: 10.1093/jnci/83.20.1450. J Natl Cancer Inst. 1991. PMID: 1920492 Review.
123 results